This up-and-coming cancer treatment could be a $25 billion market opportunity

This up-and-coming cancer treatment could be a  billion market opportunity

Skynesher | E+ | Getty Images Big pharma is betting billions on an up-and-coming class of cancer treatments that some on Wall Street are calling a “massive opportunity.” It’s called targeted radiopharmaceutical therapy. It essentially delivers radiation directly into tumors by attaching a radioactive particle to a targeting molecule. RBC Capital Markets sees a $25 … Read more

Pfizer announces new cost cutting program

Pfizer announces new cost cutting program

Exterior view of the Pfizer headquarters building in New York City on Jan. 29, 2023. Kena Betancur | Corbis News | Getty Images Pfizer on Wednesday said it has launched a new multiyear program to reduce costs as it works to rebound from the rapid decline of its Covid business.  The announcement is in addition … Read more

Eli Lilly, Novo Nordisk develop weekly insulin

Eli Lilly, Novo Nordisk develop weekly insulin

A patient injects herself with an insulin pen. Guido Krzikowski | Bloomberg | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good afternoon! The rivalry between Eli Lilly and Novo Nordisk extends beyond a buzzy class of weight loss and diabetes drugs called GLP-1s.  … Read more

FDA approves Amgen small cell lung cancer treatment

FDA approves Amgen small cell lung cancer treatment

The Amgen headquarters in Thousand Oaks, California. Eric Thayer | Bloomberg | Getty Images The Food and Drug Administration on Thursday approved Amgen‘s therapy for patients with the most deadly form of lung cancer.  The agency cleared the drug, which will be marketed under the name Imdelltra, as a second or later line of treatment … Read more

Roche weight loss drug shows promising results in early trial

Roche weight loss drug shows promising results in early trial

A logo at the Roche Holding AG headquarters in Basel, Switzerland, on Thursday, Feb. 1, 2024. Bloomberg | Getty Images Roche on Thursday said its experimental weight loss drug showed promising results in an early-stage trial, boosting the company’s bid to compete in the booming market for those treatments. The Swiss company joined a slate of … Read more

Walgreens to offer cheaper opioid overdose drug

Walgreens to offer cheaper opioid overdose drug

A person rides past a Walgreens truck, owned by the Walgreens Boots Alliance, in Manhattan, New York City, on Nov. 26, 2021. Andrew Kelly | Reuters Walgreens on Wednesday said it will offer its own cheaper version of the over-the-counter opioid overdose reversal spray naloxone. The drug is available online and will be in all … Read more

1 in 8 adults have taken GLP-1s like Ozempic: survey

1 in 8 adults have taken GLP-1s like Ozempic: survey

Rebekah Carl poses with her prescription of Wegovy in New Columbia, Pennsylvania, U.S., November 13, 2023.  Hannah Beier | Reuters Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good afternoon! The use of a buzzy class of weight loss and diabetes medications is more common … Read more

Wegovy patients maintain weight loss for 4 years: Novo Nordisk study

Wegovy patients maintain weight loss for 4 years: Novo Nordisk study

Boxes of Wegovy made by Novo Nordisk are seen at a pharmacy in London, Britain March 8, 2024.  Hollie Adams | Reuters Patients taking Novo Nordisk‘s obesity drug Wegovy maintained an average of 10% weight loss for up to four years, according to a new analysis published Tuesday from the longest clinical trial to date … Read more

OpenAI is first company to be No. 1 on Disruptor 50 two years in a row

OpenAI is first company to be No. 1 on Disruptor 50 two years in a row

It’s a first for the annual CNBC Disruptor 50 list: a company landing at No. 1 for the second year in a row. Perhaps no surprise, that company is OpenAI. More than any other startup in the 12-year history of the Disruptor 50 list, OpenAI’s disruptive impact and potential is unparalleled. What’s distinct about the … Read more

Novavax stock jumps on Sanofi Covid vaccine deal

Novavax stock jumps on Sanofi Covid vaccine deal

A vial labelled “Novavax V COVID-19 Vaccine” is seen in this illustration taken January 16, 2022.  Dado Ruvic | Reuters Shares of Novavax jumped as much as 50% on Monday as Wall Street cheered the company’s new multibillion-dollar deal with French drugmaker Sanofi that sparked a dramatic turnaround for the struggling vaccine maker. Novavax’s stock … Read more